Comstock Inc. LODE

Healthcare SIC 2860 - Industrial Organic Chemicals NYSE

Comstock commercializes innovative technologies, systems and supply chains that extract, process, and convert under-utilized waste and natural resources into clean energy and supporting products, including sustainable solutions that produce renewed and repurposed electrification metals and minerals from end-of-life solar panels. Bioleum Corporation ("Bioleum"), the Company's subsidiary, seeks to commercialize technologies that produce renewable fuels from waste, energy crops and other forms of woody biomass.

We approach the challenge of sustainability head-on by innovating, developing and commercializing technologies that accomplish more while utilizing fewer natural resources, protecting our ecosystem from the negative impact of carbon emissions and toxic materials, and enabling and empowering the next industrial revolution. Our plans to generate these throughputs involve deploying, integrating, partnering and licensing our technologies within a purpose-driven and designed ecosystem, including extended and interdependent partners that leverage their infrastructures, capacities, and resources, that are often directly integrated with our system.

Last close 3.11 2026-09-04
Market cap $236.3M 2026-06-30 share count
52-week range 2.35 - 4.98

Valuation FY2025 figures against the last close

P/S152.1x
P/E
P/FCF
EV/EBITDA
Dividend yield
Diluted EPS-1.17

Annual financial statements

Income statement

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue $1.6M$3.0M$1.3M$178.2K$862.2K$201.7K$179.6K$150.3K$104.3K$5.1M
Cost of revenue $2.6M$451.9K$0$0$272.1K$51.9K
Gross profit -$1.1M$2.6M$1.3M$178.2K$590.1K$149.8K
R&D $12.3M$19.1M$6.1M$7.0M$414.8K$0
SG&A $20.7M$12.7M$12.6M$10.2M$5.5M$4.4M$3.3M$3.4M$2.6M$3.5M
Total operating expenses $37.1M$42.2M$13.9M$19.5M$7.0M$5.6M$5.5M$7.6M$9.0M$15.3M
Operating income -$38.1M-$39.7M-$12.6M-$19.4M-$6.4M-$5.5M-$5.3M-$7.4M-$8.9M-$10.2M
Interest expense $1.9M$3.0M$1.6M$1.7M$168.9K$421.9K$879.5K$1.4M$1.7M$753.7K
Pre-tax income $43.1M$53.3M$10.5M-$46.7M-$30.3M$14.9M-$3.8M-$9.5M-$10.6M-$13.0M
Income tax $0$0$0$0$5.7M$0$0$0$0$0
Net income -$43.2M-$53.4M$10.5M-$46.7M-$24.6M$14.9M-$3.8M-$9.5M-$10.6M-$13.0M
EPS, basic -1.17-3.210.87-0.62-0.490.49-0.20-0.26-0.37
EPS, diluted -1.17-3.210.87-0.62-0.490.49-0.20-0.79-1.29-0.37
Shares, diluted (wtd. avg.) $36.7M$16.6M$10.5M$74.5M$50.4M$30.6M$19.5M$41.1M$35.3M

Balance sheet

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents $17.0M$954.3K$3.8M$2.5M$5.9M$2.4M$1.0M$488.7K$2.1M$184.4K
Short-term investments $0$18.9M$0
Receivables $1.3M$2.4M$26.4K$5.0M$0
Inventory $0
Total current assets $20.7M$12.6M$23.2M$30.8M$13.8M$20.8M$13.3M$8.6M$7.7M$8.0M
Property, plant and equipment $29.9M$8.6M$15.2M$13.5M$14.6M$8.6M$7.9M$9.7M$12.8M$15.1M
Goodwill $1.5M$0$0$12.8M$0
Other intangibles $24.9M$5.9M$15.9M$17.7M$23.2M$0
Total assets $169.6M$91.3M$106.5M$100.1M$127.0M$43.1M$39.6M$28.6M$31.0M$33.8M
Accounts payable $2.3M$2.9M$1.3M$714.1K$633.2K$313.8K$922.6K$405.1K$321.3K$804.6K
Short-term debt $0$97.6K$4.5M$1.8M$0$3.6M$328.1K$309.8K$291.5K$483.7K
Total current liabilities $10.0M$8.1M$14.8M$31.6M$23.9M$4.8M$4.4M$2.4M$1.1M$2.4M
Long-term debt $0$8.4M$5.4M$6.1M$4.5M$0$5.1M$8.9M$10.0M$9.0M
Total liabilities $58.7M$31.5M$28.2M$43.7M$34.0M$11.3M$16.1M$19.2M$19.1M$19.4M
Retained earnings -$378.7M-$335.7M-$282.3M-$291.5M-$245.5M-$221.0M-$235.9M-$232.1M-$222.6M-$212.0M
Total equity $107.6M$59.8M$78.3M$56.4M$93.0M$31.8M$23.5M$9.4M$11.9M$14.4M

Cash flow

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Operating cash flow -$24.4M-$13.9M-$13.6M-$12.1M-$7.5M-$3.8M-$2.3M-$4.0M-$6.5M-$2.6M
Depreciation and amortisation $1.2M$567.6K$435.7K$3.3M$1.0M$1.2M$1.8M$3.1M$4.2M$5.9M
Stock-based compensation $41.8K-$2.3K$482.0K$464.0K$204.2K$0$0$18.9K
Capital expenditure $1.8M$1.0M$78.5K$130.8K$2.4M$1.7M$1.8M$746.5K
Investing cash flow -$22.0M-$6.5M$3.6M-$3.7M-$16.1M$3.2M$2.6M-$1.6M$979.3K$2.6M
Financing cash flow $62.4M$17.6M$11.3M$12.4M$27.1M$2.0M$192.1K$4.1M$7.4M-$1.4M

Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001437749-26-011938.

Others in SIC 2860

TickerCompanyMarket capP/ERevenue growth
IFF INTERNATIONAL FLAVORS & FRAGRANCES INC $22.03B -5.2%
LYB LyondellBasell Industries N.V. $20.52B -9.7%
WLK WESTLAKE CORP $9.56B -8.0%
NEU NEWMARKET CORP $8.14B 19.9x -2.2%
SXT SENSIENT TECHNOLOGIES CORP $5.74B 42.7x 3.5%
REX REX AMERICAN RESOURCES Corp $1.38B 16.6x 1.2%
GPRE Green Plains Inc. $1.08B 16.0%
WLKP Westlake Chemical Partners LP $771.2M 2.7%